Cargando…

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2

Background: Emergence of vaccine-escaping SARS-CoV-2 variants is a serious problem for global public health. The currently rampant Omicron has been shown to possess remarkable vaccine escape; however, the selection pressure exerted by vaccines might pave the way for other escape mutants in the near...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koyama, Takahiko, Miyakawa, Kei, Tokumasu, Reitaro, S Jeremiah, Sundararaj, Kudo, Michiharu, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966691/ https://www.ncbi.nlm.nih.gov/pubmed/35350884 http://dx.doi.org/10.2217/fmb-2022-0025

Ejemplares similares

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2
por: Miyakawa, Kei, et al.
Publicado: (2022)

Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic Games
por: Koyama, Takahiko, et al.
Publicado: (2022)

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2022)

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2021)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

Phosphopeptide enrichment using Phos-tag technology reveals functional phosphorylation of the nucleocapsid protein of SARS-CoV-2
por: Ino, Yoko, et al.
Publicado: (2022)

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination
por: Kato, Hideaki, et al.
Publicado: (2022)

Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System
por: Yamaoka, Yutaro, et al.
Publicado: (2022)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages
por: Xiang, Tiandan, et al.
Publicado: (2022)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
por: Goto, Atsushi, et al.
Publicado: (2023)

Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
por: Miyakawa, Kei, et al.
Publicado: (2015)

Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
por: Kubo, Sousuke, et al.
Publicado: (2021)

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
por: Qu, Panke, et al.
Publicado: (2022)

Prospective Clinical Evaluation of the Diagnostic Accuracy of a Highly Sensitive Rapid Antigen Test Using Silver Amplification Technology for Emerging SARS-CoV-2 Variants
por: Obata, Kazuaki, et al.
Publicado: (2022)

Role of claudin species–specific dynamics in reconstitution and remodeling of the zonula occludens
por: Yamazaki, Yuji, et al.
Publicado: (2011)

Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
por: Jian, Fanchong, et al.
Publicado: (2022)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
por: Miyakawa, Kei, et al.
Publicado: (2022)

PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation
por: Miyakawa, Kei, et al.
Publicado: (2019)

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy
por: Hatayama, Yasuyoshi, et al.
Publicado: (2022)

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
por: Tea, Fiona, et al.
Publicado: (2021)

Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor
por: Funabashi, Rikako, et al.
Publicado: (2021)

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
por: Kato, Hideaki, et al.
Publicado: (2022)

Evaluating Clinical Genome Sequence Analysis by Watson for Genomics
por: Itahashi, Kota, et al.
Publicado: (2018)

An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB
por: He, Qingwen, et al.
Publicado: (2023)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Zhang, Yandi, et al.
Publicado: (2021)

Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes
por: Anastassopoulou, Cleo, et al.
Publicado: (2021)

SARS-COV-2 Variants: Differences and Potential of Immune Evasion
por: Hirabara, Sandro M., et al.
Publicado: (2022)

Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein
por: Uzoeto, Henrietta Onyinye, et al.
Publicado: (2022)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

The Hepatitis C Virus Glycan Shield and Evasion of the Humoral Immune Response
por: Helle, François, et al.
Publicado: (2011)

Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
por: Uraki, Ryuta, et al.
Publicado: (2023)

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
por: Aggarwal, Anupriya, et al.
Publicado: (2022)

Variant analysis of SARS-CoV-2 genomes
por: Koyama, Takahiko, et al.
Publicado: (2020)

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
por: Lazarevic, Ivana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_co0qtua5poconi2vsbjqe1v8ko